Laparoscopically assisted vs open oesophagectomy for patients with oesophageal cancer – the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial (RCT)

Rachel Brierley, Daisy M. Gaunt, Chris Metcalfe, Jane M Blazeby, Natalie S Blencowe, Marcus Jepson, Richard Berrisford, K N L Avery, William Hollingworth, Caoimhe T Rice, Aida Moure-Fernandez, Newton Alexander Wong, Joanna Nicklin, Anna Skilton, Alex Boddy, James Byrne, Tim Underwood, Ravi Vohra, James A Catton, Kish PursnaniR Melhado , Bilal Alkhaffaf, Richard Krysztopik, Peter Lamb, Lucy A Culliford, Chris A Rogers, Benjamin Howes, Katy Chalmers, Sian Cousins, Jackie Elliott, Jenny Donovan, Rachel Heys, Robin A Wickens, Paul Wilkerson, Andrew Hollowood, Christopher Streets, Dan Titcomb, M Lee Humphreys, Tim Wheatley, Grant Sanders, Arun Ariyarathenam, Jamie Kelly, Fergus Noble, Graeme W Couper, Richard J.E Skipworth, Christopher Deans, Sukhbir Ubhi, Rob Williams, David Bowrey, David Exon, Paul Turner, Vinutha Shetty, Ram Chaparala, Khurshid Akhtar, Naheed Farooq, Simon L Parsons, Neil T Welch, Rebecca J Houlihan, Joanne Smith, Rachel Schranz, Nicola Rea, Jill Cooke, Alexandra Williams, Carolyn Hindmarsh, Sally Maitland, Lucy Howie, C Paul Barham

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Introduction: Surgery (oesophagectomy), with neoadjuvant chemo(radio)therapy, is the main curative treatment for patients with oesophageal cancer. Several surgical approaches can be used to remove an oesophageal tumour. The Ivor Lewis (two phase procedure) is usually used in the UK. This can be performed as an open oesophagectomy (OO), a laparoscopically-assisted oesophagectomy (LAO) or a totally minimally invasive oesophagectomy (TMIO). All three are performed in the NHS, with LAO and OO the most common. However, there is limited evidence about which surgical approach is best for patients in terms of survival and post-operative health-related quality of life.
Methods and analysis: We will undertake a UK multicentre randomised controlled trial to compare LAO with OO in adult patients with oesophageal cancer. The primary outcome is patient-reported physical function at 3 and 6 weeks post-operatively and 3 months post-randomisation. Secondary outcomes include: post-operative complications, survival, disease recurrence, other measures of quality of life, spirometry, success of patient blinding and quality assurance measures. A cost-effectiveness analysis will be performed comparing LAO with OO. We will embed a randomised IDEAL phase 2b sub-study to evaluate the safety and evolution of the TMIO procedure and a qualitative recruitment intervention to optimise patient recruitment. We will analyse the primary outcome using a multi-level regression model. Patients will be monitored for up to 3 years after their surgery.
Ethics and dissemination: This study received approval from South-West Frenchay Research Ethics Committee. We will submit the results for publication in a peer-reviewed journal.
Original languageEnglish
JournalBMJ Open
DOIs
Publication statusPublished - 19 Nov 2019

Fingerprint

Dive into the research topics of 'Laparoscopically assisted vs open oesophagectomy for patients with oesophageal cancer – the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial (RCT)'. Together they form a unique fingerprint.

Cite this